Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
BMC Medicine
|
April 6, 2025
Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data
Marine Massy, Stefanie Marti, Helly Hammer, et al.
Therapeutische Umschau. Revue Therapeutique
|
July 22, 2021
[Healthy diet in primary and secondary prevention of stroke]
Antonela Bicvic, Helly Hammer, Hakan Sarikaya, et al.
CNS Neuroscience & Therapeutics
|
January 21, 2022
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort
Maximilian Pistor, Helly Hammer, Anke Salmen, et al.
European Journal of Neurology
|
June 26, 2024
Sex- and age-related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials
A Leon Betancourt, Robert Hoepner, Helly Hammer, et al.
International Review of Neurobiology
|
August 29, 2022
Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD)
Lara Diem, Helly Hammer, Robert Hoepner, et al.
JAMA Network Open
|
November 29, 2023
Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
Stefanie Marti, Andreas G F Hoepner, Helly Hammer, et al.
Therapeutische Umschau. Revue Therapeutique
|
May 18, 2022
[Primary CNS Vasculitis - An Overview]
Helly Hammer, Nicole Kamber, Christoph Friedli, et al.
Cureus
|
August 18, 2025
Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective Study
Lara Diem, Simona Daepp, Vincenzo P Introcaso, et al.
Therapeutic Advances in Neurological Disorders
|
May 28, 2021
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
Christoph Friedli, Lara Diem, Helly Hammer, et al.
Wiener Klinische Wochenschrift
|
June 15, 2026
Monitoring physical activity by fitness tracking devices : Usage, acceptance and willingness to share data in patients with multiple sclerosis
Helly Hammer, Robert Hoepner, Marie Louise Aicher, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
BMC Medicine
|
April 6, 2025
Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data
Marine Massy, Stefanie Marti, Helly Hammer, et al.
Therapeutische Umschau. Revue Therapeutique
|
July 22, 2021
[Healthy diet in primary and secondary prevention of stroke]
Antonela Bicvic, Helly Hammer, Hakan Sarikaya, et al.
CNS Neuroscience & Therapeutics
|
January 21, 2022
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort
Maximilian Pistor, Helly Hammer, Anke Salmen, et al.
European Journal of Neurology
|
June 26, 2024
Sex- and age-related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials
A Leon Betancourt, Robert Hoepner, Helly Hammer, et al.
International Review of Neurobiology
|
August 29, 2022
Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD)
Lara Diem, Helly Hammer, Robert Hoepner, et al.
JAMA Network Open
|
November 29, 2023
Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
Stefanie Marti, Andreas G F Hoepner, Helly Hammer, et al.
Therapeutische Umschau. Revue Therapeutique
|
May 18, 2022
[Primary CNS Vasculitis - An Overview]
Helly Hammer, Nicole Kamber, Christoph Friedli, et al.
Cureus
|
August 18, 2025
Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective Study
Lara Diem, Simona Daepp, Vincenzo P Introcaso, et al.
Therapeutic Advances in Neurological Disorders
|
May 28, 2021
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
Christoph Friedli, Lara Diem, Helly Hammer, et al.
Wiener Klinische Wochenschrift
|
June 15, 2026
Monitoring physical activity by fitness tracking devices : Usage, acceptance and willingness to share data in patients with multiple sclerosis
Helly Hammer, Robert Hoepner, Marie Louise Aicher, et al.
Page
of 3